These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37034751)

  • 1. Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study.
    Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT
    Res Sq; 2023 Mar; ():. PubMed ID: 37034751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.
    Chen YH; Lin RR; Huang HF; Xue YY; Tao QQ
    Front Aging Neurosci; 2022; 14():848180. PubMed ID: 35847667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
    Delvenne A; Gobom J; Tijms B; Bos I; Reus LM; Dobricic V; Kate MT; Verhey F; Ramakers I; Scheltens P; Teunissen CE; Vandenberghe R; Schaeverbeke J; Gabel S; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Tsolaki M; Freund-Levi Y; Lovestone S; Streffer J; Barkhof F; Bertram L; Blennow K; Zetterberg H; Visser PJ; Vos SJB
    Alzheimers Dement; 2023 Mar; 19(3):807-820. PubMed ID: 35698882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes.
    Pillai JA; Khrestian M; Bena J; Leverenz JB; Bekris LM
    Front Aging Neurosci; 2021; 13():676744. PubMed ID: 34276339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging Initiative.
    Allegri RF; Chrem Méndez P; Calandri I; Cohen G; Martín ME; Russo MJ; Crivelli L; Pertierra L; Tapajóz F; Clarens MF; Campos J; Nahas FE; Vázquez S; Surace E; Sevlever G
    Alzheimers Dement (Amst); 2020; 12(1):e12026. PubMed ID: 32490138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
    van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
    Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders.
    Li JQ; Bi YL; Shen XN; Wang HF; Xu W; Tan CC; Dong Q; Wang YJ; Tan L; Yu JT;
    Transl Neurodegener; 2020 Nov; 9(1):41. PubMed ID: 33228804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.
    Wang ML; Zou QQ; Sun Z; Wei XE; Li PY; Wu X; Li YH;
    Alzheimers Res Ther; 2022 Dec; 14(1):185. PubMed ID: 36514127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non-converter Alzheimer's disease subjects with consideration for their amyloid beta status.
    Morar U; Izquierdo W; Martin H; Forouzannezhad P; Zarafshan E; Unger E; Bursac Z; Cabrerizo M; Barreto A; Vaillancourt DE; DeKosky ST; Loewenstein D; Duara R; Adjouadi M
    Alzheimers Dement (Amst); 2022; 14(1):e12258. PubMed ID: 35229014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease trajectories in older adults with non-AD pathologic change and comparison with Alzheimer's disease pathophysiology: A longitudinal study.
    Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT;
    Neurobiol Aging; 2024 Feb; 134():106-114. PubMed ID: 38056216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of modified dementia risk score with cerebrospinal fluid biomarkers and cognition in adults without dementia.
    Li QY; Fu Y; Cui XJ; Wang ZT; Tan L;
    Front Aging Neurosci; 2024; 16():1339163. PubMed ID: 39081396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia.
    Shen XN; Li JQ; Wang HF; Li HQ; Huang YY; Yang YX; Tan L; Dong Q; Yu JT;
    Alzheimers Dement (Amst); 2020; 12(1):e12104. PubMed ID: 33005724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's disease.
    Quesnel MJ; Labonté A; Picard C; Bowie DC; Zetterberg H; Blennow K; Brinkmalm A; Villeneuve S; Poirier J; ;
    Alzheimers Dement; 2024 Sep; 20(9):6008-6031. PubMed ID: 39072932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.